| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Paula Cloghessy is See Remarks at MCRB. Paula Cloghessy's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $90K at current prices.
The MCRB filings lean toward selling, a net 2,904 shares.
Paula Cloghessy has 5 Form 4 filings on record from February 2022 to April 2026, across 2 companies: Chief People Officer at Kailera Therapeutics, Inc. Common Stock (KLRA), 2026; Seres Therapeutics (MCRB), 2022–2023.
The 9 reported transactions were 6 option or other derivative awards, 1 option exercise, 1 open-market sale and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $4K.
The only open-market sale was 2,904 shares of MCRB at an average $1.35 on October 30, 2023, about $4K. Twelve months later MCRB was down 47%.